This Insider Has Just Sold Shares In RaySearch Laboratories

We'd be surprised if RaySearch Laboratories AB (publ) (STO:RAY B) shareholders haven't noticed that the Independent Director, Gunther Marder, recently sold kr2.0m worth of stock at kr234 per share. The eyebrow raising move amounted to a reduction of 12% in their holding.

Check out our latest analysis for RaySearch Laboratories

RaySearch Laboratories Insider Transactions Over The Last Year

In fact, the recent sale by Gunther Marder was the biggest sale of RaySearch Laboratories shares made by an insider individual in the last twelve months, according to our records. That means that even when the share price was below the current price of kr245, an insider wanted to cash in some shares. We generally consider it a negative if insiders have been selling, especially if they did so below the current price, because it implies that they considered a lower price to be reasonable. While insider selling is not a positive sign, we can't be sure if it does mean insiders think the shares are fully valued, so it's only a weak sign. This single sale was just 12% of Gunther Marder's stake.

Insiders in RaySearch Laboratories didn't buy any shares in the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

For those who like to find hidden gems this free list of small cap companies with recent insider purchasing, could be just the ticket.

Does RaySearch Laboratories Boast High Insider Ownership?

Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. RaySearch Laboratories insiders own about kr2.0b worth of shares (which is 23% of the company). I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.

What Might The Insider Transactions At RaySearch Laboratories Tell Us?

An insider hasn't bought RaySearch Laboratories stock in the last three months, but there was some selling. And even if we look at the last year, we didn't see any purchases. But since RaySearch Laboratories is profitable and growing, we're not too worried by this. It is good to see high insider ownership, but the insider selling leaves us cautious. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. At Simply Wall St, we found 1 warning sign for RaySearch Laboratories that deserve your attention before buying any shares.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.